1. Home
  2. EXTR vs AKRO Comparison

EXTR vs AKRO Comparison

Compare EXTR & AKRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EXTR
  • AKRO
  • Stock Information
  • Founded
  • EXTR 1996
  • AKRO 2017
  • Country
  • EXTR United States
  • AKRO United States
  • Employees
  • EXTR N/A
  • AKRO N/A
  • Industry
  • EXTR Telecommunications Equipment
  • AKRO Biotechnology: Pharmaceutical Preparations
  • Sector
  • EXTR Telecommunications
  • AKRO Health Care
  • Exchange
  • EXTR Nasdaq
  • AKRO Nasdaq
  • Market Cap
  • EXTR 2.0B
  • AKRO 2.4B
  • IPO Year
  • EXTR 1999
  • AKRO 2019
  • Fundamental
  • Price
  • EXTR $16.56
  • AKRO $32.26
  • Analyst Decision
  • EXTR Strong Buy
  • AKRO Strong Buy
  • Analyst Count
  • EXTR 5
  • AKRO 7
  • Target Price
  • EXTR $19.00
  • AKRO $43.20
  • AVG Volume (30 Days)
  • EXTR 1.4M
  • AKRO 571.1K
  • Earning Date
  • EXTR 10-30-2024
  • AKRO 11-08-2024
  • Dividend Yield
  • EXTR N/A
  • AKRO N/A
  • EPS Growth
  • EXTR N/A
  • AKRO N/A
  • EPS
  • EXTR N/A
  • AKRO N/A
  • Revenue
  • EXTR $1,033,270,000.00
  • AKRO N/A
  • Revenue This Year
  • EXTR $1.95
  • AKRO N/A
  • Revenue Next Year
  • EXTR $8.69
  • AKRO N/A
  • P/E Ratio
  • EXTR N/A
  • AKRO N/A
  • Revenue Growth
  • EXTR N/A
  • AKRO N/A
  • 52 Week Low
  • EXTR $10.50
  • AKRO $13.47
  • 52 Week High
  • EXTR $18.77
  • AKRO $37.00
  • Technical
  • Relative Strength Index (RSI)
  • EXTR 70.01
  • AKRO 60.98
  • Support Level
  • EXTR $14.97
  • AKRO $32.70
  • Resistance Level
  • EXTR $17.02
  • AKRO $35.11
  • Average True Range (ATR)
  • EXTR 0.60
  • AKRO 1.68
  • MACD
  • EXTR 0.25
  • AKRO 0.19
  • Stochastic Oscillator
  • EXTR 97.41
  • AKRO 69.07

About EXTR Extreme Networks Inc.

Extreme Networks Inc provides cloud networking solutions and industry services and support. Extreme designs, develops, and manufactures wired, wireless, and software-defined wide area-network (SD- WAN) infrastructure equipment, software and cloud-based network management solutions. The company's cloud solution is a single platform that offers unified network management of wireless access points, switches, and SD-WAN. The company operates in a single segment which develops and markets network infrastructure equipment. Roughly half of the firm's revenue is generated in the Americas, with the rest coming from Europe, the Middle East, Africa, and Asia-Pacific.

About AKRO Akero Therapeutics Inc.

Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis, or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that has the potential to address the core processes underlying NASH pathogenesis.

Share on Social Networks: